116 related articles for article (PubMed ID: 26152922)
21. C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target.
Chanvorachote P; Sriratanasak N; Nonpanya N
Anticancer Res; 2020 Feb; 40(2):609-618. PubMed ID: 32014901
[TBL] [Abstract][Full Text] [Related]
22. B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer.
Tan J; Lee PL; Li Z; Jiang X; Lim YC; Hooi SC; Yu Q
Cancer Cell; 2010 Nov; 18(5):459-71. PubMed ID: 21075311
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA MILNR1 retards colorectal cancer growth by inhibiting c-Myc.
Gu H; Xia Y; Guo L; Wang Z; Wu S; Xu Y; Zhang Y; Huang J; Lei Y; Hu W
Cancer Commun (Lond); 2020 Sep; 40(9):456-460. PubMed ID: 32697425
[No Abstract] [Full Text] [Related]
24. Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen.
Masuo T; Okamura S; Zhang Y; Mori M
Cancer Lett; 2009 Nov; 285(1):66-72. PubMed ID: 19481339
[TBL] [Abstract][Full Text] [Related]
25. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
[TBL] [Abstract][Full Text] [Related]
26. The BET-Bromodomain Inhibitor JQ1 synergized ABT-263 against colorectal cancer cells through suppressing c-Myc-induced miR-1271-5p expression.
Wu Z; Hu Z; Han X; Li Z; Zhu Q; Wang Y; Zheng Q; Yan J
Biomed Pharmacother; 2017 Nov; 95():1574-1579. PubMed ID: 28950657
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
Kwak Y; Yun S; Nam SK; Seo AN; Lee KS; Shin E; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
J Transl Med; 2017 Aug; 15(1):167. PubMed ID: 28764718
[TBL] [Abstract][Full Text] [Related]
28. Ursolic acid promotes colorectal cancer cell apoptosis and inhibits cell proliferation via modulation of multiple signaling pathways.
Lin J; Chen Y; Wei L; Shen A; Sferra TJ; Hong Z; Peng J
Int J Oncol; 2013 Oct; 43(4):1235-43. PubMed ID: 23900560
[TBL] [Abstract][Full Text] [Related]
29. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
[TBL] [Abstract][Full Text] [Related]
30. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
31. Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae.
Kalimutho M; Bain AL; Mukherjee B; Nag P; Nanayakkara DM; Harten SK; Harris JL; Subramanian GN; Sinha D; Shirasawa S; Srihari S; Burma S; Khanna KK
Mol Oncol; 2017 May; 11(5):470-490. PubMed ID: 28173629
[TBL] [Abstract][Full Text] [Related]
32. Use of the OM-11-906 monoclonal antibody for determining p62 c-myc expression by flow cytometry in relation to prognosis in colorectal cancer.
Rowley S; Carpenter R; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
Eur J Surg Oncol; 1991 Aug; 17(4):370-8. PubMed ID: 1874294
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of long non-coding RNA prostate cancer-associated ncRNA transcript 1 inhibits multidrug resistance and c-Myc-dependent aggressiveness in colorectal cancer Caco-2 and HT-29 cells.
Qiao L; Liu X; Tang Y; Zhao Z; Zhang J; Liu H
Mol Cell Biochem; 2018 Apr; 441(1-2):99-108. PubMed ID: 28884413
[TBL] [Abstract][Full Text] [Related]
34. A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.
D'Angelo L; Piazzi G; Pacilli A; Prossomariti A; Fazio C; Montanaro L; Graziani G; Fogliano V; Munarini A; Bianchi F; Belluzzi A; Bazzoli F; Ricciardiello L
Carcinogenesis; 2014 Oct; 35(10):2314-20. PubMed ID: 25123131
[TBL] [Abstract][Full Text] [Related]
35. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
[TBL] [Abstract][Full Text] [Related]
36. Effects of siRNA targeting c-Myc and VEGF on human colorectal cancer Volo cells.
Tai J; Wang G; Liu T; Wang L; Lin C; Li F
J Biochem Mol Toxicol; 2012 Dec; 26(12):499-505. PubMed ID: 23169760
[TBL] [Abstract][Full Text] [Related]
37. c-Myc as a therapeutic target in cancer.
Prochownik EV
Expert Rev Anticancer Ther; 2004 Apr; 4(2):289-302. PubMed ID: 15056059
[TBL] [Abstract][Full Text] [Related]
38. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
Lee CW; Ito K; Ito Y
Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
[TBL] [Abstract][Full Text] [Related]
39. Cancer therapeutics: targeting the dark side of Myc.
Ponzielli R; Katz S; Barsyte-Lovejoy D; Penn LZ
Eur J Cancer; 2005 Nov; 41(16):2485-501. PubMed ID: 16243519
[TBL] [Abstract][Full Text] [Related]
40. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin.
Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
BMC Cancer; 2016 Sep; 16(1):730. PubMed ID: 27619912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]